Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
132 |
|
Actual shortage: | 30 (23%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 0 (0%) | |
Resolved: | 102 (77%) | |
Discontinuation Reports |
29 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 29 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
33 (20%) |
|
Overdue reports |
15 (50%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MINT-GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-19 | 2024-03-19 | 222750 |
MINT-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-01-29 | 2024-01-30 | 217696 |
MINT-ATORVASTATIN | 20MG | TABLET | Resolved | 2024-01-29 | 2024-01-30 | 217693 |
MINT-ATORVASTATIN | 10MG | TABLET | Resolved | 2024-01-29 | 2024-01-30 | 217690 |
MINT-TOPIRAMATE | 200MG | TABLET | Actual shortage | 2024-01-29 | 2024-01-29 | 217687 |
MINT-TOPIRAMATE | 100MG | TABLET | Actual shortage | 2024-01-29 | 2024-01-29 | 217684 |
MINT-TOPIRAMATE | 25MG | TABLET | Resolved | 2024-01-29 | 2024-03-26 | 217681 |
MINT-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-26 | 2024-01-26 | 217396 |
MINT-QUETIAPINE XR | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-26 | 2024-03-26 | 217393 |
MINT-QUETIAPINE XR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-26 | 2024-03-26 | 217390 |
MINT-QUETIAPINE XR | 150MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-26 | 2024-01-26 | 217387 |
MINT-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-26 | 2024-01-26 | 217384 |
MINT-PRAVASTATIN | 40MG | TABLET TABLET | Resolved | 2024-01-26 | 2024-03-26 | 217381 |
MINT-PRAVASTATIN | 20MG | TABLET TABLET | Actual shortage | 2024-01-26 | 2024-03-25 | 217378 |
MINT-PRAVASTATIN | 10MG | TABLET TABLET | Resolved | 2024-01-26 | 2024-03-26 | 217375 |
MINT-LETROZOLE | 2.5MG | TABLET | Actual shortage | 2024-01-26 | 2024-01-26 | 217372 |
MINT-ANASTROZOLE | 1MG | TABLET | Resolved | 2024-01-26 | 2024-03-26 | 217369 |
MINT-ALENDRONATE | 70.0MG | TABLET | Actual shortage | 2024-01-26 | 2024-01-26 | 217366 |
MINT-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-07-24 | 2024-01-09 | 199939 |
MINT-DICLOFENAC | 0.1% | SOLUTION | Actual shortage | 2023-03-27 | 2023-09-27 | 188045 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MINT-CLOPIDOGREL | 75MG | TABLET | Discontinued | 2018-08-16 | 2018-08-17 | 58286 |
MINT-CLOPIDOGREL | 75MG | TABLET | Discontinued | 2018-08-16 | 2018-08-17 | 58283 |
MINT-RIVASTIGMINE | 4.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13565 |
MINT-RIVASTIGMINE | 1.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13562 |
MINT-RIVASTIGMINE | 6MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13559 |
MINT-RIVASTIGMINE | 3MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13556 |
MINT-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13553 |
MINT-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13544 |
MINT-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13540 |